Browsing Category
Healthcare Newsdesk
96 posts
8.3% constant currency revenue growth in H1 as customers gradually return to labs
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) — Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group”…
Transparency Notification
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH, OF THE LAW…
Replacement Announcement for Selection to Participate in Research Project
DXS INTERNATIONAL PLC (AQSE: DXSP) Selection to participate in Research Project DXS International plc (“DXSP” or the “Company”),…
Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
Conference call to be held on March 4, 2021 at 8:30 am ET/1:30 pm GMT LONDON, March 04,…
Statement re Selection to Participate in Research Project
DXS INTERNATIONAL PLC (AQSE: DXSP) Selection to Participate in Research Project DXS International plc (“DXS” or the “Company”),…
Silence Therapeutics to Present at the Barclays Global Healthcare Conference
Silence Therapeutics to Present at the Barclays Global Healthcare Conference 4 March 2021 LONDON, Silence Therapeutics plc, AIM:…
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities and equipment to…
Freeline to Present at Upcoming Investor Conferences
LONDON, March 02, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a…
Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
$150M Strategic Financing Supports Execution into the First Half of 2023 OTL-203 Achieves Proof of Concept (POC) in…
COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021
New York, March 02, 2021 (GLOBE NEWSWIRE) — London, UK – 2 March 2021 COMPASS Pathways plc…
